These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9846912)
21. Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience. Miravitlles M; Vidal R; Barros-Tizón JC; Bustamante A; España PP; Casas F; Martínez MT; Escudero C; Jardi R Respir Med; 1998 Oct; 92(10):1181-7. PubMed ID: 9926146 [TBL] [Abstract][Full Text] [Related]
22. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma. van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537 [TBL] [Abstract][Full Text] [Related]
23. Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency. Seersholm N; Kok-Jensen A Thorax; 1998 Apr; 53(4):265-8. PubMed ID: 9741368 [TBL] [Abstract][Full Text] [Related]
24. Heritability of lung function in severe alpha-1 antitrypsin deficiency. DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508 [TBL] [Abstract][Full Text] [Related]
26. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Turino GM; Barker AF; Brantly ML; Cohen AB; Connelly RP; Crystal RG; Eden E; Schluchter MD; Stoller JK Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1718-25. PubMed ID: 8970361 [TBL] [Abstract][Full Text] [Related]
27. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency. Piitulainen E; Tanash HA COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290 [TBL] [Abstract][Full Text] [Related]
28. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E Thorax; 2008 Dec; 63(12):1091-5. PubMed ID: 18682522 [TBL] [Abstract][Full Text] [Related]
29. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function. Eriksson S; Lindell SE; Wiberg R Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302 [TBL] [Abstract][Full Text] [Related]
30. Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ. Wu MC; Eriksson S J Clin Epidemiol; 1988; 41(12):1157-65. PubMed ID: 3264848 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values. Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901 [TBL] [Abstract][Full Text] [Related]
32. Clinical, epidemiologic, and pulmonary function studies in alpha,-antitrypsin-deficient subjects of Pi Z type. Rawlings W; Kreiss P; Levy D; Cohen B; Menkes H; Brashears S; Permutt S Am Rev Respir Dis; 1976 Nov; 114(5):945-53. PubMed ID: 1086622 [TBL] [Abstract][Full Text] [Related]
33. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits. Tanash HA; Ekström M; Rönmark E; Lindberg A; Piitulainen E Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28889108 [TBL] [Abstract][Full Text] [Related]
34. Heterozygous alpha 1-antitrypsin deficiency: a longitudinal lung function study. de Hamel FA; Carrell RW N Z Med J; 1981 Dec; 94(697):407-10. PubMed ID: 6977750 [TBL] [Abstract][Full Text] [Related]
35. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population. Silva GE; Sherrill DL; Guerra S; Barbee RA Chest; 2003 May; 123(5):1435-40. PubMed ID: 12740258 [TBL] [Abstract][Full Text] [Related]
36. Passive smoking and lung function in alpha(1)-antitrypsin heterozygote schoolchildren. Corbo GM; Forastiere F; Agabiti N; Dell'Orco V; Pistelli R; Massi G; Perucci CA; Valente S Thorax; 2003 Mar; 58(3):237-41. PubMed ID: 12612303 [TBL] [Abstract][Full Text] [Related]
37. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management? Stockley RA; Edgar RG; Pillai A; Turner AM Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086 [TBL] [Abstract][Full Text] [Related]
38. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Dahl M; Nordestgaard BG; Lange P; Vestbo J; Tybjaerg-Hansen A Clin Chem; 2001 Jan; 47(1):56-62. PubMed ID: 11148177 [TBL] [Abstract][Full Text] [Related]
39. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med; 1998 Jul; 158(1):49-59. PubMed ID: 9655706 [TBL] [Abstract][Full Text] [Related]
40. The effect of habitual waterpipe tobacco smoking on pulmonary function and exercise capacity in young healthy males: A pilot study. Hawari FI; Obeidat NA; Ghonimat IM; Ayub HS; Dawahreh SS Respir Med; 2017 Jan; 122():71-75. PubMed ID: 27993294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]